Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pathfinder

Investor type Angel Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 87
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 70
Rounds per year 6.69
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 20
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • Mobile
  • Health Care
  • E-Commerce
  • Internet
Summary

Pathfinder is the famous Corporate Investor, which was founded in 2015. The leading representative office of defined Corporate Investor is situated in the Leuven. The company was established in Europe in Belgium.

Among the various public portfolio startups of the fund, we may underline Credit Karma, SendGrid, Twilio Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2009. The fund is constantly included in 7-12 deals per year. When the investment is from Pathfinder the average startup value is 10-50 millions dollars.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Pathfinder, startups are often financed by Founders Fund, Techstars Boulder Accelerator, Techstars. The meaningful sponsors for the fund in investment in the same round are Uncork Capital, Founders Fund, Techstars Ventures. In the next rounds fund is usually obtained by 500 Startups, Felicis Ventures, Uncork Capital.

This organization was formed by Noor Ilani.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pathfinder:
Typical Co-investors
Pathfinder is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pathfinder:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anhui Zhongding Sealing Parts Anhui, China, Ningguo
Big Red Ventures Ithaca, New York, United States
GAIN Capital Maryland, New Jersey, United States
GENTOSHA MediaConsulting Japan, Tokyo
Jiaxing Yueling -
Limburg Business Development Fund (LBDF) -
Newable Private Investing England, London, United Kingdom
Novaquest Capital Management North Carolina, Raleigh, United States
o3 Capital India, Maharashtra, Mumbai
PSG Boston, Massachusetts, United States
RMKB Ventures -
Shanghua Hegui Touzi China, Chongming, Chongming District
Shanxi Heling Touzi guanli Co., Ltd. China, Shaanxi, Xian Shi
SPD International Australia, Melbourne, Victoria
Squadron Medical Finance Solutions -
Taprogge Germany, Hesse, Hessen
TinkBig Venture Kuala Lumpur, Malaysia
Vortex Partners Addison, Texas, United States
Yunshi Capital Chengdu, China, Sichuan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Teiko.bio

Biotechnology
Health Care
Health Diagnostics
Medical
$11M05 Oct 2021 Salt Lake City, Utah, United States

Industrial Automation
Manufacturing
Personal Health
Pharmaceutical
Robotics
$20M14 Apr 2021 San Francisco, California, United States

Booste

E-Commerce
Financial Services
FinTech
27 Jan 2021 Szczecin, West Pomeranian Voivodeship, Poland

Lolli

Apps
Bitcoin
Consumer
Cryptocurrency
E-Commerce
FinTech
Internet
$3M11 May 2020 New York, New York, United States

Literati

Children
Content
Parenting
Publishing
$12M23 Oct 2019 Austin, Texas, United States

Health Care
$3M23 Sep 2019 Los Angeles, California, United States

Blockfolio

Bitcoin
Blockchain
Cryptocurrency
Financial Services
FinTech
Mobile Apps
Virtual Currency
$2M05 Aug 2019 Santa Monica, California, United States

Athena Security

Artificial Intelligence
Computer Vision
Cyber Security
Education
Health Care
Information Technology
Machine Learning
Physical Security
Security
Software
$5M13 Jun 2019 Austin, Texas, United States

Crea

E-Commerce
05 Jun 2019 Thailand
News
Lolli Raises $5M in Pre-Series Funding

– Lolli is a NYC-based bitcoin rewards company.
– In March 2021 the company raised $5m in Pre-Series funding.
– The round was led by Seven Seven Six, Night Media, Serena Ventures, Casey Neistat, Phil Defranco, Cody Ko, Noel Miller, Ian Borthwick, and Gabriel Leydon.
– The funding follows a previous $3m seed round led by PathFinder, Founders Fund’s early-stage investment vehicle, and included Ashton Kutcher and Guy Oseary’s Sound Ventures, Michelle Phan, Digital Currency Group, and Bain Capital.

Multiply Labs Raises $20M in Series A Funding

– Multiply Labs, a San Francisco, CA-based robotics company developing automated manufacturing systems for the production of individualized drugs, raised $20m in Series A funding.
– The round was led by Casdin Capital with participation from new investors Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle, Fifty Years and Garage Capital.
– In conjunction with the funding, Michael Doherty, a representative of Casdin Capital, will join Multiply Labs’ Board of Directors.
– The company intends to use the funds to grow its installed robotic production capacity, and to apply its tech to new life-saving therapies.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pathfinder?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: